Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
02/26/2003 | EP1285070A1 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular pha depolymerase |
02/26/2003 | EP1285069A1 Anti-listeria bacteriocin |
02/26/2003 | EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
02/26/2003 | EP1285067A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
02/26/2003 | EP1285066A1 F-box containing protein |
02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
02/26/2003 | EP1285062A1 Vector constructs |
02/26/2003 | EP1285003A1 Use of a secondary cell wall polymer of procaryotic microorganisms |
02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
02/26/2003 | EP1186654A4 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
02/26/2003 | EP0944734B1 Bacillus strain and antibiotic screening method |
02/26/2003 | EP0822986B1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
02/26/2003 | EP0728191B1 A secretion sequence for the production of a heterologous protein in yeast |
02/26/2003 | EP0665882B1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
02/26/2003 | EP0579730B1 Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics |
02/26/2003 | EP0293443B1 Construction of synthetic dna and its use in large polypeptide synthesis |
02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
02/26/2003 | CN1399676A 碱性芽孢杆菌淀粉酶 Alkaline Bacillus Amylase |
02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
02/26/2003 | CN1398982A Two-phase fast tubercle bacillus culture medium and its prepn |
02/26/2003 | CN1398979A Fermentation process of ash tree flower and production process of its polyglycopeptide |
02/26/2003 | CN1398978A Fermentation process of Agaricus Blazei murrill and production process of its polyglycopeptide |
02/26/2003 | CN1398970A Glacial nuclear active gene and its expression vector and engineering bacterium |
02/26/2003 | CN1398967A Solid fermentation of waste residue and waste water to produce pectase |
02/26/2003 | CN1398966A Acidophilic thermostable mycose-base synthetase and its prepn and use |
02/26/2003 | CN1398964A Prepn of L-arginine |
02/26/2003 | CN1398894A Bioactive peptide No.26 |
02/26/2003 | CN1398893A Bioactive peptide No.27 |
02/26/2003 | CN1398892A Bioactive peptide No.28 |
02/26/2003 | CN1398891A Bioactive peptide No.12 |
02/26/2003 | CN1398890A Bioactive peptide No.13 |
02/26/2003 | CN1398889A Bioactive peptide No.18 |
02/26/2003 | CN1398888A Bioactive peptide No.29 |
02/26/2003 | CN1398887A Bioactive peptide No.11 |
02/26/2003 | CN1398886A Bioactive peptide No.17 |
02/26/2003 | CN1398885A Bioactive peptide No.7 |
02/26/2003 | CN1398884A Bioactive peptide No.30 |
02/26/2003 | CN1398883A Bioactive peptide No.24 |
02/26/2003 | CN1398882A Bioactive peptide No.21 |
02/26/2003 | CN1398881A Bioactive peptide No.23 |
02/26/2003 | CN1398880A Bioactive peptide No.22 |
02/26/2003 | CN1398879A Bioactive peptide No.14 |
02/26/2003 | CN1398878A Bioactive peptide No.16 |
02/26/2003 | CN1398877A Bioactive peptide No.15 |
02/26/2003 | CN1398824A Bioorganic fertilizer and its production process |
02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
02/25/2003 | US6525190 Amidase |
02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
02/25/2003 | US6525178 PGC-1, a novel brown fat PPARgamma coactivator |
02/25/2003 | US6524998 Biological compositions and methods for enhancing plant growth and health and producing disease-suppressive plants |
02/25/2003 | US6524856 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
02/25/2003 | US6524841 Recombinant megalomicin biosynthetic genes and uses thereof |
02/25/2003 | US6524839 Method for enhancing catalytic activity of cells |
02/25/2003 | US6524837 Hydantoinase variants with improved properties and their use for the production of amino acids |
02/25/2003 | US6524834 Protein capable of hydrolyzing organophosphorous acetylcholinesterase inhibitors for use as poison antedote |
02/25/2003 | US6524831 For producing coniferyl alcohol from eugenol in presence of eugenol hydroxylase; producing coniferylaldehyde from coniferyl alcohol in presence of coniferyl alcohol dehydrogenase; producing ferulic acid from coniferylaldehyde |
02/25/2003 | US6524828 Mutant of RNA polymerases with increased stability |
02/25/2003 | US6524826 Polynucleotides encoding cortistatin polypeptides |
02/25/2003 | US6524821 Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof |
02/25/2003 | US6524820 Lectins and coding sequences |
02/25/2003 | US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia |
02/25/2003 | US6524817 DNA encoding a receptor subunit for oncostatin M |
02/25/2003 | US6524816 Expression element |
02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
02/25/2003 | US6524811 Methods of increasing or decreasing carotenoids and other isoprenoids using IPP isomerase |
02/25/2003 | US6524810 Making a non-viable preparation of cells by the addition of bleomycin/phleomycin anitibiotics which retains signal-generating metabolic activity such as bioluminescence |
02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
02/25/2003 | US6524802 Methods of detecting growth differentiation factor-14 |
02/25/2003 | US6524799 DNA encoding sparc-related proteins |
02/25/2003 | US6524789 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
02/25/2003 | US6524577 Strain of Streptomyces for controlling plant diseases |
02/25/2003 | US6524576 Probiotic composition; veterinary feed additive; food additive; microorganisms dispenser; eliminating an oil pollution; restoring organic fumes degrading microorganism population in a biofilter |
02/25/2003 | US6524575 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
02/25/2003 | CA2185362C Purified nucleic acid encoding a thermostable pyrophosphatase |
02/25/2003 | CA2099841C Expression of recombinant proteins in attenuated bacteria |
02/25/2003 | CA2039718C Chimeric dna-rna catalytic sequences |
02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
02/20/2003 | WO2003014386A2 Method for identifying macrocyclic polyketides |
02/20/2003 | WO2003014380A2 Microoroganisms and cells for diagnosis and therapy of tumors |
02/20/2003 | WO2003014370A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
02/20/2003 | WO2003014363A1 Vector for site-specific integration of heterologous dna sequences into the rdn a sites of methylotrophic yeasts |
02/20/2003 | WO2003014362A2 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
02/20/2003 | WO2003014361A1 Novel recombinant gene expression method by stop codon suppression |
02/20/2003 | WO2003014360A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
02/20/2003 | WO2003014359A2 A fusion protein |
02/20/2003 | WO2003014354A1 Tyrosyl-trna synthase variants |
02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
02/20/2003 | WO2003014351A2 Stress-associated genetic products from ashbya gossypii |
02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
02/20/2003 | WO2003014341A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
02/20/2003 | WO2003014331A1 Erythrocytic cells and method for preserving cells |
02/20/2003 | WO2003014330A2 Coryneform bacteria which produce chemical compounds ii |
02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
02/20/2003 | WO2003014318A2 Methods for treating diabetes and other blood sugar disorders |